Based on the excellent sensitivity and specificity of this simple “double-hit” (Claudin-4 and BAP1) panel for discriminating mesothelioma with epithelioid features from conventional carcinoma [3], we replicated the same study design in the setting of sarcomatoid neoplasms, namely SM versus SC. The gene discussed is BAP1; the disease is carcinoma.